News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
141,498 Results
Type
Article (6002)
Company Profile (49)
Press Release (135447)
Section
Business (46227)
Career Advice (240)
Deals (8938)
Drug Delivery (15)
Drug Development (20021)
Employer Resources (21)
FDA (3470)
Job Trends (3637)
News (77154)
Policy (5630)
Tag
Academia (462)
Accelerated approval (4)
Adcomms (4)
Allergies (36)
Alliances (7731)
ALS (36)
Alzheimer's disease (299)
Antibody-drug conjugate (ADC) (67)
Approvals (3601)
Artificial intelligence (68)
Autoimmune disease (23)
Automation (2)
Bankruptcy (44)
Best Places to Work (3045)
BIOSECURE Act (2)
Biosimilars (42)
Biotechnology (29)
Bladder cancer (47)
Brain cancer (12)
Breast cancer (159)
Cancer (1106)
Cardiovascular disease (117)
Career advice (200)
Career pathing (6)
CAR-T (54)
CDC (11)
Cell therapy (133)
Cervical cancer (12)
Clinical research (18116)
Collaboration (204)
Compensation (165)
Complete response letters (7)
COVID-19 (585)
CRISPR (16)
C-suite (75)
Cystic fibrosis (40)
Data (1709)
Depression (20)
Diabetes (111)
Diagnostics (1352)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (35)
Drug pricing (21)
Drug shortages (6)
Duchenne muscular dystrophy (44)
Earnings (33276)
Editorial (3)
Employer resources (20)
Events (18978)
Executive appointments (87)
FDA (4297)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (204)
Gene editing (43)
Generative AI (7)
Gene therapy (85)
GLP-1 (201)
Government (753)
Grass and pollen (1)
Guidances (292)
Healthcare (4258)
HIV (11)
Huntington's disease (13)
IgA nephropathy (21)
Immunology and inflammation (36)
Immuno-oncology (6)
Indications (25)
Infectious disease (669)
Inflammatory bowel disease (39)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (29)
Interviews (30)
IPO (5448)
IRA (4)
Job creations (746)
Job search strategy (176)
Kidney cancer (5)
Labor market (25)
Layoffs (107)
Leadership (1)
Legal (947)
Liver cancer (18)
Lung cancer (138)
Lymphoma (149)
Machine learning (5)
Management (10)
Manufacturing (113)
MASH (50)
Medical device (3044)
Medtech (3054)
Mergers & acquisitions (3714)
Metabolic disorders (287)
Multiple sclerosis (40)
NASH (4)
Neurodegenerative disease (46)
Neuropsychiatric disorders (18)
Neuroscience (539)
NextGen: Class of 2025 (1170)
Non-profit (962)
Now hiring (5)
Obesity (117)
Opinion (26)
Ovarian cancer (37)
Pain (25)
Pancreatic cancer (45)
Parkinson's disease (41)
Partnered (11)
Patents (55)
Patient recruitment (84)
Peanut (24)
People (6365)
Pharmaceutical (17)
Pharmacy benefit managers (5)
Phase I (4806)
Phase II (7744)
Phase III (6985)
Pipeline (1700)
Policy (31)
Postmarket research (648)
Preclinical (1477)
Press Release (14)
Prostate cancer (45)
Psychedelics (7)
Radiopharmaceuticals (62)
Rare diseases (160)
Real estate (1028)
Recruiting (10)
Regulatory (4745)
Reports (16)
Research institute (423)
Resumes & cover letters (42)
Rett syndrome (4)
RSV (55)
Schizophrenia (44)
Series A (24)
Series B (23)
Service/supplier (2)
Sickle cell disease (26)
Special edition (5)
Spinal muscular atrophy (81)
Sponsored (6)
Startups (477)
Stomach cancer (2)
Supply chain (21)
Tariffs (11)
The Weekly (2)
Vaccines (211)
Venture capital (13)
Weight loss (78)
Women's health (12)
Worklife (2)
Date
Today (30)
Last 7 days (118)
Last 30 days (513)
Last 365 days (7566)
2025 (7442)
2024 (8761)
2023 (9909)
2022 (12431)
2021 (13101)
2020 (12328)
2019 (10223)
2018 (7761)
2017 (6645)
2016 (5816)
2015 (7362)
2014 (5208)
2013 (3762)
2012 (3973)
2011 (4354)
2010 (3904)
Location
Africa (125)
Alabama (21)
Alaska (1)
Arizona (40)
Arkansas (1)
Asia (8459)
Australia (1067)
California (2343)
Canada (876)
China (236)
Colorado (107)
Connecticut (88)
Delaware (102)
Europe (20060)
Florida (379)
Georgia (76)
Idaho (11)
Illinois (198)
India (11)
Indiana (121)
Iowa (3)
Japan (109)
Kansas (26)
Kentucky (6)
Louisiana (10)
Maine (51)
Maryland (299)
Massachusetts (1703)
Michigan (51)
Minnesota (111)
Mississippi (1)
Missouri (25)
Montana (2)
Nebraska (2)
Nevada (21)
New Hampshire (30)
New Jersey (1003)
New Mexico (6)
New York (701)
North Carolina (340)
North Dakota (3)
Northern California (1210)
Ohio (60)
Oklahoma (1)
Oregon (5)
Pennsylvania (520)
Rhode Island (11)
South America (201)
South Carolina (2)
Southern California (898)
Tennessee (27)
Texas (280)
United States (8870)
Utah (65)
Vermont (1)
Virginia (27)
Washington D.C. (26)
Washington State (202)
West Virginia (1)
Wisconsin (59)
141,498 Results for "60".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
Amgen Hops on DTC Train To Offer Repatha at 60% Discount
Amgen will offer its lipid-lowering drug Repatha directly to patients for $239 per month, representing a nearly 60% reduction from the current wholesale acquisition cost of $527.70.
October 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026
December 12, 2025
·
10 min read
Press Releases
NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
December 15, 2025
·
4 min read
Press Releases
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results
November 14, 2025
·
5 min read
Press Releases
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
December 2, 2025
·
5 min read
Press Releases
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
December 1, 2025
·
5 min read
Press Releases
ADC Therapeutics Announces $60 Million Private Placement
October 14, 2025
·
9 min read
Press Releases
Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
November 14, 2025
·
6 min read
Rare diseases
Biohaven Cuts R&D Spending by 60% After FDA Rejection of Drug for Rare Neurodegenerative Disease
Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to the progressive loss of control over movement.
November 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Avenzo Therapeutics Announces $60 Million Series B Financing
September 23, 2025
·
2 min read
1 of 14,150
Next
